The automated cell counters market consists of equipment used for counting cells present in a cell suspension. Automated cell counters are automated hematology analyzers or flow cytometers that have the ability to count and determine the volume and dimensions of cells within a given specimen. These analyzers are used to analyze blood and body fluids and provide a complete blood count, which includes cell counts of red blood cells (RBCs), white blood cells (WBCs), and platelets along with hemoglobin levels. Automated cell counters provide precise and accurate cell count measurement in a quick, easy, and cost-effective manner compared to manual microscopic cell counting.
The global automated cell counters market is estimated to be valued at US$ 3.75 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan. Thermo Fisher Scientific is the market leader with over 30% market share owing to its wide product portfolio and geographical presence.
The rising prevalence of various diseases such as cancer, infectious diseases and growing applications of cell biology research are expected to drive growth of the automated cell counters market during the forecast period. Furthermore, increasing biotechnology and pharmaceutical industry research and development spending is also anticipated to boost demand.
Major players are focusing on expanding their presence in emerging markets of Asia Pacific and Latin America through partnerships and new product launches. For instance, in 2022, Thermo Fisher Scientific launched several new cell imaging systems and cell analysis instruments to strengthen its position in China and India.
Market drivers and Restrain:
The rising prevalence of cancer is a major market driver. Cancer causes abnormal cell growth with the potential to invade or spread to other parts of the body. Automated cell counters help in the effective diagnosis and management of cancers by enabling accurate cell counts.
High costs of automated cell counters is a major market restraint. Advanced automated cell counters equipped with novel technologies can cost over 0.1-1 million dollars. This high price can limit adoption, especially in price sensitive emerging markets. Additionally, requirements of specialized equipment handling, regular maintenance and repair services also increase the overall cost of ownership.
Segment Analysis
The hematology analyzers segment is dominating the market. Hematology analyzers provides accurate and fast cell counting and differentiation. They are widely used in hospitals, diagnostic labs, research institutions and biopharma companies for analyzing samples like blood, urine and other body fluids. The compact type of these analyzers are gaining higher popularity as they provide point-of-care testing and require less space in low volume settings like physician offices and small diagnostic labs.
Flow cytometers are emerging as a fast growing sub segment. Flow cytometers provide multiparametric analysis of cells and are used for applications like disease diagnosis, stem cell research, and immunophenotyping. The development of high throughput flow cytometers integrated with advanced software is driving their adoption in research institutions and biopharma companies for screening large number of samples.
Global Analysis
North America dominates the automated cell counters market due to presence of advanced healthcare infrastructure and big biopharma industry. The U.S. is the largest market in North America. Growing investments by government and private organizations in life science research is fueling the demand.
Asia Pacific is projected to be the fastest growing regional market during the forecast period. Developing countries like China and India are witnessing increasing healthcare expenditures. Improving diagnostic capabilities and expanding biotech industry is propelling the automated cell counters market in Asia Pacific.
Other regions including Europe and Latin America are also exhibiting significant growth due to growing application of automated cell counters in clinical research and disease diagnosis.
No comments:
Post a Comment